Tag: Healthcare Advocacy

Advocacy for Regulatory Flexibility in Rare Disease Therapies

Explore the urgent call for regulatory flexibility in rare disease therapies, as industry leaders seek solutions to expedite drug approvals amid strict FDA guidelines.

Medicare Home Health Reimbursement Cut Looms Amid Shutdown Delay

The 2026 Medicare home health final rule release is delayed due to the government shutdown. Proposed 9% reimbursement cuts spark industry-wide concern and strategic responses from key providers and advocacy groups.